NEW YORK, June 5, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into CAE, Inc. (NYSE: CAE) for possible violations of the federal securities laws. If you have invested in CAE, you are encouraged to obtain additional information by visiting

Why did CAE stock fall?

On May 21, 2024, CAE announced preliminary results for the fourth quarter of 2024 and that it had initiated a “re-baselining” of its defense business due to eight underperforming legacy fixed-price contracts. CAE further reported that it had taken a $568.0 million non-cash impairment charge on defense goodwill, $90.3 million of adverse defense contract earnings adjustments, and a $35.7 million impairment charge on related technology and other non-financial assets primarily related to the existing contracts.

As a result, CAE’s stock price fell more than 13% when it opened on May 22, 2024, and closed down more than 5%. BFA is investigating whether CAE and certain of its executives made materially false and/or misleading statements to investors regarding the legacy contracts and/or its defense activities.

Click here for more information:

What can you do?

If you are in CAE, Inc. has invested, you may have legal options and are encouraged to provide your information to the company. All representation is on a contingency fee basis at no cost to you. Shareholders are not responsible for any legal fees or costs of proceedings. The company will seek court approval for any fees and costs.

Send your details to:

Or contact:
Ross Shikowitz
[email protected]

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder derivative disputes. It was named one of the top 5 plaintiffs’ law firms by ISS SCAS in 2023 and its lawyers have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among recent notable successes, BFA has recovered more than $900 million in value from the Board of Directors of Tesla, Inc. (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit

Advertising lawyer. Past results do not guarantee future results.